Drugmakers Call for More Flexible Templates for REMS

Drug Industry Daily
A A
Parts of the FDA’s recently updated draft guidance on the content and formatting of REMS documents are overly prescriptive, stakeholders said in public comments to the agency.

To View This Article:

Login

Subscribe To Drug Industry Daily